Doctor profile · Federal record
Dr. Lekshmi Santhosh, M.D.
Pulmonary Disease Physician (CMS: Interventional Pain Management) · Student in an Organized Health Care Education/Training Program · San Francisco, CA
- NPI 1669761953
- Accepts Medicare
- MIPS 70.8 / 100 · 2023
- 15 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4150 Clement St
San Francisco, CA 941211545
(415) 750-2129
fax (415) 750-6614
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- May 29, 2020
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- California #A122723
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669761953. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
258
Distinct HCPCS
4
Medicare allowed
$36,921
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 86 | 41 | $35 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 76 | 56 | $162 | |
99291 |
Critical care, first 30-74 minutes | 62 | 27 | $237 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 34 | 34 | $203 |
In context: peer comparison
Among 14 peers in San Francisco Pulmonary Disease Physician, average services per provider: 55. This provider delivers 4.7× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
245
Patients
17
Total drug cost
$152,825
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 59 | 17 | $48,302 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 34 | 0 | $14,176 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 27 | 0 | $595 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 19 | 0 | $6,929 |
| Fluticasone Propionate | Generic | 18 | 0 | $349 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 16 | 0 | $8,839 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 14 | 0 | $834 |
| Flovent Hfa (Fluticasone Propionate) | Brand | 12 | 0 | $3,522 |
| Omeprazole | Generic | 12 | 0 | $243 |
| Pirfenidone | Generic | 12 | 0 | $68,574 |
Hospital affiliations
Frequently asked questions
What is Dr. Lekshmi Santhosh's medical specialty?
Dr. Lekshmi Santhosh practices Pulmonary Disease Physician in San Francisco, CA.
Where does Dr. Lekshmi Santhosh practice?
Dr. Lekshmi Santhosh practices at 4150 Clement St, San Francisco, CA 941211545. Office phone: 4157502129.
What is Dr. Lekshmi Santhosh's NPI?
Dr. Lekshmi Santhosh's National Provider Identifier (NPI) is 1669761953, issued by NPPES.
Does Dr. Lekshmi Santhosh accept Medicare assignment?
Yes. Dr. Lekshmi Santhosh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lekshmi Santhosh commonly perform?
Top Medicare-reported procedures in 2023: Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS G2212); Established patient office or other outpatient visit (HCPCS 99215); Critical care (HCPCS 99291). Source: CMS Medicare Physician & Other Practitioners file.